Glimirace MP 2mg/500mg/15mg Tablet
Marketer
Hemera Life Sciences Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimirace MP 2mg/500mg/15mg Tablet
Metformin/Glimepiride/Pioglitazone 2mg/500mg/15mg tablets offer combined blood glucose regulation. This medication, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It facilitates improved insulin use, consequently reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in this case, omit the missed dose and resume the regular schedule. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or meal skipping may trigger hypoglycemia. Regular blood sugar monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor prior to commencing treatment. Pregnant or lactating individuals require medical consultation before use. Kidney function tests are typically assessed before treatment initiation. Limit alcohol consumption as it might heighten side effect risk.
Primary Ingredients of Glimirace MP 2mg/500mg/15mg Tablet
No text was provided to rephrase. Please provide the text you wish me to rewrite.
Uses of Glimirace MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimirace MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimirace MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
Common Side effects of Glimirace MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimirace MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimirace MP 2mg/500mg/15mg tablets with food.
How Glimirace MP 2mg/500mg/15mg Tablet works:
Glimirace MP 2mg/500mg/15mg tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to optimize blood sugar management when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimirace MP 2mg/500mg/15mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimirace MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimirace MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimirace MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimirace MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Glimirace MP 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimirace MP 2mg/500mg/15mg Tablet :
Should you forget a Glimirace MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimirace MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently